Risky antibiotic use threatens patients
Patients are willing to use antibiotics without contacting a medical professional, according to a study published in Antimicrobial Agents and Chemotherapy.
Do Clothes Make the Pharmacist?
People are looking--and judging.
Are You Safe at Work?
Retail pharmacies are in the news a lot these days. Unfortunately, it is not the kind of news anyone wants to hear.
Top vaccination errors-and how to avoid them
Pharmacists help to combat meningococcal disease
As bacterial meningitis spikes in certain regions of the U.S. and with more schools recommending vaccination, some pharmacy chains are helping to combat the disease.
What the new biosimilar means for U.S. healthcare
Physicians and pharmacists welcomed FDA’s recent approval of etanercept-szzs (Erelzi), a biosimilar to Amgen’s top-selling Enbrel for rheumatoid arthritis, plaque psoriasis, and other inflammatory conditions.
Biosimilar naming method questioned
FDA’s method for naming biosimilars and interchangeable biologics came under fire long before the first biosimilar, Zarxio, was approved last spring.
When someone else pays, Rx costs soar
Why are Rx drugs so expensive? No one seems to have a good answer.
Tobacco products taboo in pharmacies according to two thirds of U.S. adults
Researchers reported that nearly half of cigarette smokers, as well as nearly half of tobacco users who don’t smoke cigarettes, support such a policy.
Health Mart, Publix pharmacies top customer-satisfaction rankings
Both brick-and-mortar and mail-order pharmacies receive high scores when it comes to customer satisfaction, according to J.D. Power’s 2016 U.S. Pharmacy Study.
Pharmacist interventions boost adherence for minorities
Pharmacist intervention is one primary way that adherence to cholesterol-lowering medications can be improved in minority neighborhoods, a recent study found.
Study: Biosimilars as safe as branded drugs
New study finds that biosimilar medications for arthritis and other diseases areas safe and effective as their brand-name counterparts.
New Products for Pharmacists 08-10-2016
New branded drugs, new generics.
Compounding services can help your pharmacy stand out
Dennis Song, RPh, describes the steps to take when starting a compounding services business.
Why pharmacists are concerned about the safety of biosimilars
Pharmacists and other healthcare professionals are looking to the FDA for more guidance on biosimilars and interchangeability with their reference products.
The red pen rules: How to prevent pharmacy error
Anxious new pharmacists get a shot in the arm from columnist Pete Kreckel, RPh.
Regs, robbery responses among top “pharmacy gamechangers” for 2016
The issues of most concern to pharmacists, outlined at McKesson’s ideaShare 2016.
Inside the U.S., European markets for biosimilars
Despite barriers to their adoption in the U.S. and Europe, biosimilars have produced healthcare savings in Europe. Similar savings are projected for the U.S. market.
Drug take-back: A call for a permanent solution
A coordinated effort needs to be made to preserve the health and safety of life on earth.
Biosimilars for cancer treatment on the U.S. horizon
Cancer treatments are expected to dominate much of the first wave of biosimilars in the U.S. This Q&A discussion looks at some of the questions pharmacists have about use of biosimilars in cancer treatment.
Easing the bite from generic drug price increases
Generic drug price hikes are not likely to disappear anytime soon. Find out why they're occurring and what can be done about them.
Every pharmacist has them - and so does every teacher
What do pharmacists and teachers - and an awful lot of other people - have in common?
Biosimilar: Coming to a pharmacy near you
Biosimilars are the future of pharmacy. When they hit community pharmacy, issues that have been important in specialty settings are going to explode.
Patient care comes first for McKesson’s 2016 Pharmacy of the Year winners
McKesson recognized some outstanding community pharmacies at this year's IdeaShare.
Adding biosimilars to formularies: The pharmacist's role
Pharmacists on P&T committees are going to face issues that range from biosimilar naming systems to challenges in dispensing and costs.
Compression stockings, AF patients at risk, and ICH outcomes
Anticoagulation briefs.
FDA approves brivaracetam for use in partial onset seizure treatment
Brivaracetam provides another adjunctive treatment option for partial onset seizures in patients with uncontrolled epilepsy.
A lesson in prospective drug review: What is your job?
What is the pharmacist’s duty? This case history may shed some light.
An overview of FDA’s 503B outsourcing facility requirements
FDA has stated that it intends to continue inspections of compounding pharmacies, and it has taken aggressive action, including enforcement actions, as appropriate to protect the public health.
Physician-pharmacist partnerships key to higher profits, future progress
Once physicians see what you can do for them, they won't want to let you go.
